Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Acetyl-11-keto-β-boswellic acid attenuates titanium particle-induced osteogenic inhibition via activation of the GSK-3β/β-catenin signaling pathway.

Xiong L, Liu Y, Zhu F, Lin J, Wen D, Wang Z, Bai J, Ge G, Xu C, Gu Y, Xu Y, Zhou J, Geng D.

Theranostics. 2019 Sep 23;9(24):7140-7155. doi: 10.7150/thno.35988. eCollection 2019.

2.

Comparative Investigation of Frankincense Nutraceuticals: Correlation of Boswellic and Lupeolic Acid Contents with Cytokine Release Inhibition and Toxicity against Triple-Negative Breast Cancer Cells.

Schmiech M, Lang SJ, Ulrich J, Werner K, Rashan LJ, Syrovets T, Simmet T.

Nutrients. 2019 Oct 2;11(10). pii: E2341. doi: 10.3390/nu11102341.

3.

An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Roy NK, Parama D, Banik K, Bordoloi D, Devi AK, Thakur KK, Padmavathi G, Shakibaei M, Fan L, Sethi G, Kunnumakkara AB.

Int J Mol Sci. 2019 Aug 22;20(17). pii: E4101. doi: 10.3390/ijms20174101. Review.

4.
5.

Acetyl-11-keto-β-boswellic acid modulates membrane dynamics in benzo(a)pyrene-induced lung carcinogenesis.

Bhardwaj P, Kumar M, Dhatwalia SK, Garg ML, Dhawan DK.

Mol Cell Biochem. 2019 Oct;460(1-2):17-27. doi: 10.1007/s11010-019-03566-z. Epub 2019 Jun 4.

PMID:
31165316
6.

Acetyl-11-keto-β-boswellic acid triggers premature senescence via induction of DNA damage accompanied by impairment of DNA repair genes in hepatocellular carcinoma cells in vitro and in vivo.

Wang S, Wang H, Sun B, Li D, Wu J, Li J, Tian X, Qin C, Chang H, Liu Y.

Fundam Clin Pharmacol. 2019 May 29. doi: 10.1111/fcp.12488. [Epub ahead of print]

PMID:
31141202
7.

3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function.

Jin L, Yingchun W, Zhujun S, Yinan W, Dongchen W, Hui Y, Xi Y, Wanzhou Z, Buluan Z, Jinhua W.

Biomed Pharmacother. 2019 Aug;116:108992. doi: 10.1016/j.biopha.2019.108992. Epub 2019 May 23.

8.

Approach For Treatment of Liver Cancer By Novel Glycyrrhizin Derivative.

El-Senduny FF, Zidane MM, Youssef MM, Badria FA.

Anticancer Agents Med Chem. 2019 Apr 11. doi: 10.2174/1871520619666190411114718. [Epub ahead of print]

PMID:
30973113
9.

New derivatives of 11-keto-β-boswellic acid (KBA) induce apoptosis in breast and prostate cancers cells.

Bini Araba A, Ur Rehman N, Al-Araimi A, Al-Hashmi S, Al-Shidhani S, Csuk R, Hussain H, Al-Harrasi A, Zadjali F.

Nat Prod Res. 2019 Apr 1:1-10. doi: 10.1080/14786419.2019.1593165. [Epub ahead of print]

PMID:
30931626
10.

Boswellic acid has anti-inflammatory effects and enhances the anticancer activities of Temozolomide and Afatinib, an irreversible ErbB family blocker, in human glioblastoma cells.

Barbarisi M, Barbarisi A, De Sena G, Armenia E, Aurilio C, Libutti M, Iaffaioli RV, Botti G, Maurea N, Quagliariello V.

Phytother Res. 2019 Jun;33(6):1670-1682. doi: 10.1002/ptr.6354. Epub 2019 Mar 28.

PMID:
30924205
11.

Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma.

Biersack B.

Noncoding RNA Res. 2018 Nov 4;3(4):213-225. doi: 10.1016/j.ncrna.2018.11.001. eCollection 2018 Dec. Review.

12.

Relations between approved platinum drugs and non-coding RNAs in mesothelioma.

Biersack B.

Noncoding RNA Res. 2018 Aug 30;3(4):161-173. doi: 10.1016/j.ncrna.2018.08.001. eCollection 2018 Dec. Review.

13.

Synthesis of new boswellic acid derivatives as potential antiproliferative agents.

Shamraiz U, Hussain H, Ur Rehman N, Al-Shidhani S, Saeed A, Khan HY, Khan A, Fischer L, Csuk R, Badshah A, Al-Rawahi A, Hussain J, Al-Harrasi A.

Nat Prod Res. 2019 Jan 29:1-8. doi: 10.1080/14786419.2018.1564295. [Epub ahead of print]

PMID:
30691289
14.

Identification of a natural inhibitor of methionine adenosyltransferase 2A regulating one-carbon metabolism in keratinocytes.

Bai J, Gao Y, Chen L, Yin Q, Lou F, Wang Z, Xu Z, Zhou H, Li Q, Cai W, Sun Y, Niu L, Wang H, Wei Z, Lu S, Zhou A, Zhang J, Wang H.

EBioMedicine. 2019 Jan;39:575-590. doi: 10.1016/j.ebiom.2018.12.036. Epub 2018 Dec 25.

15.
16.

Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.

Liu YQ, Wang SK, Xu QQ, Yuan HQ, Guo YX, Wang Q, Kong F, Lin ZM, Sun DQ, Wang RM, Lou HX.

Acta Pharmacol Sin. 2019 May;40(5):689-698. doi: 10.1038/s41401-018-0157-9. Epub 2018 Aug 31.

PMID:
30171201
17.

Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.

Huang M, Li A, Zhao F, Xie X, Li K, Jing Y, Liu D, Zhao L.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3187-3193. doi: 10.1016/j.bmcl.2018.08.021. Epub 2018 Aug 22.

PMID:
30153964
18.

Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Kunnumakkara AB, Banik K, Bordoloi D, Harsha C, Sailo BL, Padmavathi G, Roy NK, Gupta SC, Aggarwal BB.

Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Review.

19.

Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model.

Girardi B, Principi M, Pricci M, Giorgio F, Iannone A, Losurdo G, Ierardi E, Di Leo A, Barone M.

Carcinogenesis. 2018 Oct 8;39(10):1274-1282. doi: 10.1093/carcin/bgy104.

PMID:
30084990
20.

Acetyl-11-keto-β-boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF-β/Smad signalling pathway.

Liu M, Liu T, Shang P, Zhang Y, Liu L, Liu T, Sun S.

J Cell Mol Med. 2018 Oct;22(10):4997-5007. doi: 10.1111/jcmm.13766. Epub 2018 Jul 28.

Supplemental Content

Loading ...
Support Center